{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:42:22Z","timestamp":1793878942129,"version":"4.7.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.brainresbull.2021.01.021","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T23:16:40Z","timestamp":1612307800000},"page":"246-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Haloperidol elicits oxidative damage in the brain of rats submitted to the ketamine-induced model of schizophrenia"],"prefix":"10.1016","volume":"170","author":[{"given":"Samira S.","family":"Valvassori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3075-2484","authenticated-orcid":false,"given":"Jos\u00e9 H.","family":"Cararo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Menegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taise","family":"Possamai-Della","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge M.","family":"Aguiar-Geraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6703-8914","authenticated-orcid":false,"given":"Simone Lespinasse","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Antunes","family":"Mastella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3114-6611","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra I.","family":"Zugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2021.01.021_bib0005","first-page":"253","article-title":"Brain oxidative stress and neurodegeneration in the ketamine model of schizophrenia during antipsychotic treatment: effects of N-acetylcysteine treatment","volume":"6","author":"Abdel-Salam","year":"2018","journal-title":"ROS"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0028-3908(98)00215-9","article-title":"Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation","volume":"38","author":"Balijepalli","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0015","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.neuropharm.2009.01.021","article-title":"GABAB\/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum","volume":"56","author":"Balla","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.psychres.2013.08.035","article-title":"Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate","volume":"210","author":"Bo\u0161kovi\u0107","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4161\/oxim.3.6.13446","article-title":"A rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes","volume":"3","author":"Canever","year":"2010","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pnpbp.2018.05.014","article-title":"Changes in behavioural parameters, oxidative stress and neurotrophins in the brain of adult offspring induced to an animal model of schizophrenia: the effects of FA deficient or FA supplemented diet during the neurodevelopmental phase","volume":"86","author":"Canever","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0035","first-page":"31","article-title":"Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxins","volume":"51","author":"Castagnoli","year":"1999","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0040","article-title":"Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum disorder: focus on biological pathways and epigenetic mechanisms","author":"Cattane","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbr.2010.08.001","article-title":"Effect of\u2019 chronic\u2019 versus\u2019 acute\u2019 ketamine administration and its\u2019 withdrawal\u2019 effect on behavioural alterations in mice: implications for experimental psychosis","volume":"216","author":"Chatterjee","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4077\/CJP.2018.BAG529","article-title":"Protective effect of L-theanine on haloperidol-induced orofacial","volume":"61","author":"Chen","year":"2018","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0055","series-title":"Antipsychotic Medications","author":"Chokhawala","year":"2019"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0060","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1590\/0001-3765201720160490","article-title":"The preventive effects of ascorbic acid supplementation on locomotor and acetylcholinesterase activity in an animal model of schizophrenia induced by ketamine","volume":"89","author":"Damazio","year":"2017","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0065","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1139\/cjpp-2016-0307","article-title":"Behavioral and neurochemical effects of alpha lipoic acid associated with omega-3 in tardive dyskinesia induced by chronic haloperidol in rats","volume":"95","author":"de Ara\u00fajo","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11011-011-9234-1","article-title":"Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine","volume":"26","author":"de Oliveira","year":"2011","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0075","series-title":"Medical Genetics Summaries","article-title":"Thioridazine therapy and CYP2D6 genotypes","author":"Dean","year":"2017"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12031-012-9884-4","article-title":"\u03b1-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt\/GSK-3\u03b2 signaling pathway induced by antipsychotics: Potential relevance for the treatment of schizophrenia","volume":"50","author":"Deslauriers","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/1028415X.2017.1338549","article-title":"Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats","volume":"21","author":"Dhingra","year":"2018","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/pcn.12631","article-title":"Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma","volume":"72","author":"Dietrich-Muszalska","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0095","first-page":"29","article-title":"Alleviation of haloperidol induced oxidative stress in rats: effects of sucrose vs grape seed extract","volume":"53","author":"El-Awdan","year":"2015","journal-title":"Bull. Fac. Pharm. Cairo Univ."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tiv.2017.07.008","article-title":"The role of oxidative stress in antipsychotics induced ovarian toxicity","volume":"44","author":"Elmorsy","year":"2017","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0013-7006(06)76151-6","article-title":"Oxidative stress involvement in schizophrenia pathophysiology: a review","volume":"32","author":"Fendri","year":"2006","journal-title":"Encephale"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3892\/etm.2012.822","article-title":"Determination of oxidative stress and activities of antioxidant enzymes in guinea pigs treated with haloperidol","volume":"5","author":"Gumulec","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/2045125318781475","article-title":"The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses","volume":"8","author":"Haddad","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0120","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.neuroscience.2005.01.059","article-title":"Monoaminergic dysregulation in glutathione-deficient mice: possible relevance to schizophrenia?","volume":"132","author":"Jacobsen","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0125","first-page":"1070","article-title":"Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism","volume":"19","author":"Kamyar","year":"2016","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/mp.2017.190","article-title":"The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders","volume":"23","author":"Kokkinou","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0135","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbr.2016.10.049","article-title":"Influence of magnesium supplementation on movement side effects related to typical antipsychotic treatment in rats","volume":"320","author":"Kronbauer","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/jnp.17.2.227","article-title":"Oxidative stress during treatment with first- and second-generation antipsychotics","volume":"17","author":"Kropp","year":"2005","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0145","doi-asserted-by":"crossref","first-page":"E1442","DOI":"10.3390\/ijms20061442","article-title":"NMDA receptor model of antipsychotic drug-induced hypofrontality","volume":"20","author":"Krzystanek","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03033368","article-title":"Antipsychotic-induced oxidative stress in rat brain","volume":"13","author":"Martins","year":"2008","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0155","doi-asserted-by":"crossref","first-page":"e1944","DOI":"10.1371\/journal.pone.0001944","article-title":"Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study","volume":"3","author":"Matsuzawa","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/104012371702900307","article-title":"Multiple neurotoxic effects of haloperidol resulting in neuronal death","volume":"29","author":"Nasrallah","year":"2017","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0165","series-title":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals","author":"National Research Council (US)","year":"2011"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0170","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.biopha.2017.05.094","article-title":"Melatonin attenuates behavioural deficits and reduces brain oxidative stress in a rodent model of schizophrenia","volume":"92","author":"Onaolapo","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","article-title":"Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"37","author":"Parikh","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-3701-1-12","article-title":"Neuroprotective effects of alpha lipoic acid on haloperidol-induced oxidative stress in the rat brain","volume":"1","author":"Perera","year":"2011","journal-title":"Cell Biosci."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0185","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jpsychires.2006.01.011","article-title":"Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"41","author":"Pillai","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0190","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2174\/13895575113136660100","article-title":"Haloperidol cytotoxicity and its relation to oxidative stress","volume":"13","author":"Raudenska","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2004.09.032","article-title":"Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain","volume":"372","author":"Reinke","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpsychires.2017.05.009","article-title":"Schizophrenia: a review of potential biomarkers","volume":"93","author":"Rodrigues-Amorim","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0205","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s11011-017-0002-8","article-title":"Antioxidant effects of rice bran oil mitigate repeated haloperidol-induced tardive dyskinesia in male rats","volume":"32","author":"Samad","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/0019-5545.43627","article-title":"A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia","volume":"50","author":"Singh","year":"2008","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbi.2018.09.014","article-title":"Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPAR\u03b3 receptors","volume":"74","author":"Sonego","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0220","article-title":"Ascorbic acid supplementation attenuates schizophrenia-like symptoms in an animal model induced by ketamine","author":"Supp","year":"2020","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0225","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1017\/S1461145709991040","article-title":"Chronic antipsychotic treatment: protracted decreases in phospho-TrkA levels in the rat hippocampus","volume":"13","author":"Terry","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/CJP.CJP_8_19","article-title":"Possible nitric oxide mechanism involved in the protective effect of L-theanine on haloperidol-induced orofacial dyskinesia","volume":"62","author":"Tsai","year":"2019","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2004.10.016","article-title":"Nicergoline reverts haloperidol-induced loss of detoxifying-enzyme activity","volume":"505","author":"Vairetti","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0240","series-title":"Schizophrenia","author":"World Health Organization, WHO","year":"2018"},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0245","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ejphar.2014.06.007","article-title":"Generalized estimating equation model and long-term exposure effect of antipsychotics on SH-SY5Y cells against oxidative stressors","volume":"740","author":"Yang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2021.01.021_bib0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2016.06.013","article-title":"Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamine","volume":"81","author":"Zugno","year":"2016","journal-title":"J. Psychiatr. Res."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923021000344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923021000344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:44:14Z","timestamp":1759783454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923021000344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":50,"alternative-id":["S0361923021000344"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2021.01.021","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haloperidol elicits oxidative damage in the brain of rats submitted to the ketamine-induced model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2021.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}